EHR-Based Prompt Ups Hepatitis C Screening for Baby Boomers

This article originally appeared here.
Share this content:
EHR-Based Prompt Ups Hepatitis C Screening for Baby Boomers
EHR-Based Prompt Ups Hepatitis C Screening for Baby Boomers

THURSDAY, July 20, 2017 (HealthDay News) -- Implementation of an electronic health record (EHR)-based prompt can improve hepatitis C virus (HCV) screening rates among baby boomers, according to a study published online July 17 in Hepatology.

Monica A. Konerman, M.D., from the University of Michigan in Ann Arbor, and colleagues assessed the impact of an EHR-based prompt on HCV screening rates in baby boomers. Primary care providers were prompted with an EHR-based Best Practice Advisory (BPA) to perform HCV screening for patients who were born between 1945 and 1965, had no prior diagnosis of HCV infection, and lacked prior documented HCV testing. For newly diagnosed patients, the BPA had associated educational materials, order set, and streamlined access to specialty care.

The researchers found that 52,660 baby boomers were seen in primary care clinics in the three years prior to BPA implementation, and 28 percent were screened. There was an increase in HCV screening from 7.6 percent for patients with a primary care provider visit in the six months before BPA to 72 percent in the one-year after BPA. To date, all 53 patients newly diagnosed were referred for specialty care; 11 had advanced fibrosis or cirrhosis, 20 started treatment, and nine achieved sustained viral response.

"Implementation of an EHR-based prompt increased HCV screening rates among baby boomers in primary care by five-fold due to efficiency in determining needs for HCV screening and work-flow design," the authors write.

One author disclosed financial ties to Bristol-Myers Squibb and Gilead.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »